117 results on '"Mu, Linjing'
Search Results
2. Preclinical Evaluation of the Reversible Monoacylglycerol Lipase PET Tracer (R)‐[11C]YH132: Application in Drug Development and Neurodegenerative Diseases
3. Identification of (R)-[18F]YH134 for Monoacylglycerol Lipase Neuroimaging and Exploration of Its Use for Central Nervous System and Peripheral Drug Development
4. Current Radioligands for the PET Imaging of Metabotropic Glutamate Receptors
5. Identification of (R)-[18F]YH134 as a promising reversible MAGL PET tracer and the impact of peripheral MAGL blockade on its brain uptake
6. Rapid copper-mediated radiosynthesis optimization for a novel monoacylglycerol lipase PET tracer on a high-throughput microdroplet radiochemistry platform
7. Quantitative Evaluation of a Novel PET Radioligand for the Monoacylglycerol Lipase (MAGL) in Non-Human Primates
8. Reducing kidney uptake of radiolabelled exendin-4 using variants of the renally cleavable linker MVK
9. The impact of tau deposition and hypometabolism on cognitive impairment and longitudinal cognitive decline
10. Imaging increased metabolism in the spinal cord in mice after middle cerebral artery occlusion
11. ATN profile classification across two independent prospective cohorts
12. In Vitro and In Vivo Evaluation of ABCG2 (BCRP) Inhibitors Derived from Ko143
13. Rest/stress myocardial perfusion imaging by positron emission tomography with 18F-Flurpiridaz: A feasibility study in mice
14. Proof-of-concept optimization of a copper-mediated 18F-radiosynthesis of a novel MAGL PET tracer on a high-throughput microdroplet platform and its macroscale translation
15. Multi-parameter optimization: Development of a morpholin-3-one derivative with an improved kinetic profile for imaging monoacylglycerol lipase in the brain
16. Dual MVK cleavable linkers effectively reduce renal retention of 111In-fibronectin-binding peptides
17. Evaluation of cannabinoid type 2 receptor expression and pyridine-based radiotracers in brains from a mouse model of Alzheimer’s disease
18. Imaging increased metabolism in the spinal cord in mice after middle cerebral artery occlusion
19. Evaluation of CB2R expression and pyridine-based radiotracers in brains from a mouse model of Alzheimer’s disease
20. Discovery, synthesis and evaluation of novel reversible monoacylglycerol lipase radioligands bearing a morpholine-3-one scaffold
21. Reducing the renal retention of 111In-labelled fibronectin-binding peptides through brush border-enzyme sensitive cleavable linkers
22. Structure-activity relationship of pyrazol-4-yl-pyridine derivatives for imaging the muscarinic acetylcholine receptor M4
23. Development of a novel reversible monoacylglycerol lipase PET tracer bearing a morpholine-3-one scaffold
24. Development of High Brain-Penetrant and Reversible Monoacylglycerol Lipase PET Tracers for Neuroimaging
25. Role of sex hormones in modulating myocardial perfusion and coronary flow reserve
26. High‐resolution non‐invasive whole brain imaging of tauopathy in a tauopathy mouse model
27. In vivo Imaging of Cannabinoid Type 2 Receptors: Functional and Structural Alterations in Mouse Model of Cerebral Ischemia by PET and MRI
28. Rest/Stress Myocardial Perfusion Imaging by Positron Emission Tomography with 18F-Flurpiridaz: A Feasibility Study in Mice
29. Current Radioligands for the PET Imaging of Metabotropic Glutamate Receptors
30. In Vivo Imaging of Cannabinoid Type 2 Receptors, Functional and Structural Alterations in Mouse Model of Cerebral Ischemia by PET and MRI
31. In vivo imaging of cannabinoid type 2 receptors, functional and structural alterations in mouse model of cerebral ischemia by PET and MRI
32. Development of reversible monoacylglycerol lipase PET tracers with improved brain uptake
33. On the consensus nomenclature rules for radiopharmaceutical chemistry – Reconsideration of radiochemical conversion
34. Tauvid™: The First FDA-Approved PET Tracer for Imaging Tau Pathology in Alzheimer’s Disease
35. Positron Emission Tomography Imaging of the Endocannabinoid System: Opportunities and Challenges in Radiotracer Development
36. Neuroimaging with Radiopharmaceuticals Targeting the Glutamatergic System
37. Volumetric multispectral optoacoustic tomography of beta‐amyloid deposits in whole mouse brain
38. Front Cover: Evaluation of 5 H ‐Thiazolo[3,2‐α]pyrimidin‐5‐ones as Potential GluN2A PET Tracers (ChemMedChem 24/2020)
39. [11C]mHED PET follows a two-tissue compartment model in mouse myocardium with norepinephrine transporter (NET)-dependent uptake, while [18F]LMI1195 uptake is NET-independent
40. Identification and Preclinical Development of a 2,5,6-Trisubstituted Fluorinated Pyridine Derivative as a Radioligand for the Positron Emission Tomography Imaging of Cannabinoid Type 2 Receptors
41. Preclinical Development of 18F-OF-NB1 for Imaging GluN2B-Containing N-Methyl-d-Aspartate Receptors and Its Utility as a Biomarker for Amyotrophic Lateral Sclerosis
42. Evaluation of 5 H ‐Thiazolo[3,2‐α]pyrimidin‐5‐ones as Potential GluN2A PET Tracers
43. Structure–Activity Relationship Studies of Pyridine-Based Ligands and Identification of a Fluorinated Derivative for Positron Emission Tomography Imaging of Cannabinoid Type 2 Receptors
44. Structure–Affinity Relationships of 2,3,4,5-Tetrahydro-1H-3-benzazepine and 6,7,8,9-Tetrahydro-5H-benzo[7]annulen-7-amine Analogues and the Discovery of a Radiofluorinated 2,3,4,5-Tetrahydro-1H-3-benzazepine Congener for Imaging GluN2B Subunit-Containing N-Methyl-d-aspartate Receptors
45. Synthesis and Structure–Affinity Relationship of Small Molecules for Imaging Human CD80 by Positron Emission Tomography
46. Recent progress in allosteric modulators for GluN2A subunit and development of GluN2A-selective nuclear imaging probes
47. Radiation dosimetry of [18F]-PSS232—a PET radioligand for imaging mGlu5 receptors in humans
48. Chronic Nicotine Exposure Alters Metabotropic Glutamate Receptor 5: Longitudinal PET Study and Behavioural Assessment in Rats
49. Preclinical Evaluation of Benzazepine-Based PET Radioligands (R)- and (S)-11C-Me-NB1 Reveals Distinct Enantiomeric Binding Patterns and a Tightrope Walk Between GluN2B- and σ1-Receptor–Targeted PET Imaging
50. Ketamine and Ceftriaxone-Induced Alterations in Glutamate Levels Do Not Impact the Specific Binding of Metabotropic Glutamate Receptor Subtype 5 Radioligand [18F]PSS232 in the Rat Brain
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.